DWTX
Dogwood Therapeutics, Inc.NASDAQHealthcare$2.11-3.32%ClosedMarket Cap: $4.0M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.40
P/S
0.00
EV/EBITDA
0.09
DCF Value
$0.69
FCF Yield
-400.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-56.6%
ROA
-38.0%
ROIC
-32.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | NaN% | $-3.8M | $-3.8M | $-0.26 | — |
| FY 2025 | $0.00 | NaN% | $-28.0M | $-34.3M | $-4.32 | — |
| Q3 2025 | $0.00 | NaN% | $-15.8M | $-15.7M | $-8.20 | — |
| Q2 2025 | $0.00 | NaN% | $-3.9M | $-3.8M | $-1.99 | — |
| Q1 2025 | $0.00 | NaN% | $-4.4M | $-10.9M | $-8.45 | — |
| Q4 2024 | $0.00 | NaN% | $-7.5M | $-7.7M | $-5.90 | — |
| FY 2024 | $0.00 | NaN% | $-12.2M | $-12.3M | $-12.52 | — |
| Q3 2024 | $0.00 | NaN% | $-2.3M | $-2.3M | $-2.05 | — |
| Q2 2024 | $0.00 | NaN% | $-1.1M | $-1.0M | $-1.15 | — |
| Q1 2024 | $0.00 | NaN% | $-1.3M | $-1.3M | $-1.68 | — |
| Q4 2023 | $0.00 | NaN% | $-1.1M | $-1.1M | $-1.43 | — |
| FY 2023 | $0.00 | NaN% | $-5.4M | $-5.3M | $-7.05 | — |